TAMSULOSIN VERSUS ALFUZOSIN IN THE TREATMENT OF LOWER URINARY TRACT SYMPTOMS
Phase 4
- Conditions
- Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
- Registration Number
- CTRI/2020/06/025806
- Lead Sponsor
- ARMED FORCES MEDICAL COLLEGE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
presenting with lower urinary tract symptoms
Exclusion Criteria
Past history of Prostate surgery, urethral stricture, bladder neck stenosis, vesical calculus, urethral or bladder diverticulum, neurogenic bladder, prostate or bladder cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study improvement in International Prostate symptom score (IPSS)Timepoint: 24 months
- Secondary Outcome Measures
Name Time Method To compare the efficacy of each drug individuallyTimepoint: 24 months